Navigation Links
Porter Novelli Named Agency of Record for Prix Galien USA Awards
Date:6/29/2011

NEW YORK, June 29, 2011 /PRNewswire/ -- Global public relations leader Porter Novelli today announced that it has been named agency of record for the Prix Galien USA Awards, which recognize excellence in biopharmaceutical research and development that has significantly improved the human condition. Porter Novelli will be responsible for raising awareness of the award in the U.S. and driving volume of submissions.

The Prix Galien is internationally renowned for recognizing the development of innovative medicines and medical technologies. Judged by a prestigious committee of scientists and clinicians, the Prix Galien is considered the industry's highest accolade. The awards are presented in the following categories, in which one to three prizes are given: Best Pharmaceutical Agent, Best Biotechnical Product and Best Medical Device.

"Innovation in medicine is something that needs to be nurtured, acknowledged and rewarded," said Susan Hayes, global director, health, Porter Novelli. "Porter Novelli is pleased to support the Prix Galien's commitment to progress in health and medicine, a goal that everyone in the health care community shares."

The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2011 Prix Galien USA Awards will be held on September 27, 2011 at the American Museum of Natural History in New York City.

As part of the events that take place around the awards, Peter Pitts, director of global regulatory and health policy at Porter Novelli, will participate in the panel discussion, "What is 'Value' and How Can it be Measured and Demonstrated in Therapeutic Innovations? Breaking Down the Barriers of the Past."

About Porter Novelli

A global public relations leader, Porter Novelli was founded in 1972 and is a part of Omnicom Group Inc. (NYSE: OMC). In 90 offices in nearly 60 countries, Porter Novelli combines the power of immersion with the rigor of research to create deep human insights that enable the agency to transform the opinions, beliefs and behaviors of those who matter most to its clients. For additional information, please visit www.porternovelli.com.

Contact:
Catherine Sullivan
Catherine.Sullivan@porternovelli.com
212-601-8315


'/>"/>
SOURCE Porter Novelli
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
4. Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
7. Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
8. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Robert Kline, President & CEO, Medivance Named Ernst & Young Entrepreneur Of The Year® 2011 Regional Award Winner
11. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 This report on the opioid induced ... of the global market. Large number of chronic pain ... constipation is a major side effect of consumption of ... targeted therapy has been prescribed to treat opioid induced ... medicines, and growing awareness about the therapy are the ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
(Date:1/19/2017)... -- According to a study conducted by Persistence Market ... a CAGR of 6.5% during the forecast period 2016-2024. According to ... be the leading market for cryotherapy globally during the forecast period  ... Highlights from the ... and adequate supply of gas in order to provide smoother maintenance ...
Breaking Medicine Technology:
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that reminds ... published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published ... high school and have many different titles,” Gaapf mentions about his different works. “I ...
Breaking Medicine News(10 mins):